Shire Announces FDA Approval of TAKHZYRO™ (lanadelumab-flyo), a First-of-its-Kind mAb Preventive Treatment for Hereditary Angioedema

World News: . []

---HAE attacks are LINK  debilitating and potentially life threatening TAKHZYRO provides the HAE LINK  with a new option for the prevention of HAE attacks said LINK  J Castaldo President US Hereditary Angioedema As sociati...

More news and information about TAKHZYRO

Published By:

Globe Newswire: 22:14 GMT Monday 27th August 2018

Published: .

Search for other references to "shire" on SPi News


Share

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
 
Privacy Policy | Terms and Conditions | Contact Us